Thanks #DDDD I asked and they delivered!
More positive results this time on MRx-4DP0004 with 83.3% of subjects showing improvements!
https://t.co/1IiPzcIgMr
Never had a chance to sell #MCLS and somewhat confused, rescue? What does that mean for my holding? https://t.co/EKzXBXgG3O
#DDDD - If its not one seller its another, up and down.... Be nice to see this Merck bid....
#HEMO - Expect IND approval soon and its at 1.4p?
@detector_trader Covid surge crash, Russia invades Ukraine crash, FED crash.... Its been non-stop crash..... American stocks might be inflated, LSE is bargain basement.
#DDDD - Holding above 40p should move back to 50p+
#HEMO - Missed RNS last week
* year end cash over £6.8m - Excellent to see!
* HEMO-CAR-T - strong progress in moving towards human trials
* Move to new facility to enable more cost-effective work
https://t.co/jFnKeWS5qw
Update to poll as 52w high now 3.05p.
If a hostile takeover of #HEMO was attempted and you were offered 3.05p per share, as a shareholder how would you vote?
The low mCap has got me thinking, if a hostile takeover of #HEMO was attempted and you were offered 14p per share, as a shareholder how would you vote?
While Boris & Rishi partied, we tried to give Ruby the best possible end of life.
A hot tub & a blow up flamingo were all we could manage. No friends, grandparents or cousins. Not even for 10 minutes.
She had to say goodbye on Zoom.
We deserve better.
#BorisTheLiar
@EquityTrader888 @CizzlePlc Well your pump for a diagnostics company is going well... Must be the massive fees per test....
As for "pointer"'s I see lots of them for unrelated companies from people I FOLLOW, not having it shoved down my throat. Cross Ramp is spot on, I chose block and report posts 👍
Here, our Founder and CEO @vmsandler catches up with @TMSreach
Listen to Vlad expand about the very large patent application, why every year is a company making year, and the massive cost savings the custom-built laboratory will make for #HEMO
https://t.co/UTUzk66Mzx
The virus killer that takes on the nuclear threat of infection…
“I firmly believe that the @HemogenyxPharma share price will follow our scientific, engineering and manufacturing promise”
#HEMO Founder and CEO @vmsandler expands further with @copytaster
https://t.co/vlLmBasl62